Evidence map›Paper›PMID 33625545›Full record

ReviewApplied microbiology and biotechnology2021

Modifications of diketopiperazines assembled by cyclodipeptide synthases with cytochrome P

Lauritz Harken, Shu-Ming Li

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Discovery of Tyrosinase Inhibitors fromCurrent issues in molecular biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Analysis of the Setomimycin Biosynthetic Gene Cluster fromInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Total synthesis of complex 2,5-diketopiperazine alkaloids.The Alkaloids. Chemistry and biology · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lauritz HarkenInstitut für Pharmazeutische Biologie und Biotechnologie, Fachbereich Pharmazie, Philipps-Universität Marburg, Robert-Koch-Str. 4, 35037, Marburg, Germany.
Shu-Ming LiInstitut für Pharmazeutische Biologie und Biotechnologie, Fachbereich Pharmazie, Philipps-Universität Marburg, Robert-Koch-Str. 4, 35037, Marburg, Germany. shuming.li@staff.uni-marburg.de.ORCID http://orcid.org/0000-0003-4583-2655
Philipps University of Marburg · DE

Funding

Deutsche Forschungsgemeinschaft INST 160/620-1Deutsche Forschungsgemeinschaft Li844/14-1
6 · The paper itself

Abstract

2,5-Diketopiperazines are the smallest cyclic peptides comprising two amino acids connected via two peptide bonds. They can be biosynthesized in nature by two different enzyme families, either by nonribosomal peptide synthetases or by cyclodipeptide synthases. Due to the stable scaffold of the diketopiperazine ring, they can serve as precursors for further modifications by different tailoring enzymes, such as methyltransferases, prenyltransferases, oxidoreductases like cyclodipeptide oxidases, 2-oxoglutarate-dependent monooxygenases and cytochrome P

Indexed as

DiketopiperazinesPeptide SynthasesAmino AcidsCytochrome P-450 Enzyme SystemHumansPeptides, CyclicProtein EngineeringAmino AcidsCytochrome P-450 Enzyme SystemDiketopiperazinesPeptides, CyclicPeptide SynthasesCyclodipeptidesCytochrome P450Diversity of cyclodipeptidesEnzymatic modification

Identifiers

PMID33625545
PMCPMC7954767
OpenAlexW3132440423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.